Literature DB >> 10640646

Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation.

K Ulbrich1, V Subr, J Strohalm, D Plocová, M Jelínková, B Ríhová.   

Abstract

This paper describes the synthesis, physico-chemical characteristics and results of selected biological tests of conjugates of antibodies or proteins with poly(HPMA) or with poly(HPMA) carriers of anti-cancer drug doxorubicin, designed for targeted cancer therapy. Two types of conjugates differing in the method of conjugation of polymer with protein were synthesized. In the first, protein is attached to the polymer via an oligopeptide sequence in the side chain of the polymer backbone and, in the second, the polymer is attached to protein via its end-chain functional group. Conjugation of an antibody with poly(HPMA) does not influence the binding activity of the antibody for cell surface antigen. The physico-chemical characteristics and biological activity of both systems depend on the detailed structure of the polymer, the type of antibody or protein moiety and the structure of the whole system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640646     DOI: 10.1016/s0168-3659(99)00141-8

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  44 in total

1.  HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.

Authors:  Sarita Rani; Avinash Gothwal; Pawan K Pandey; Devendra S Chauhan; Praveen K Pachouri; Umesh D Gupta; Umesh Gupta
Journal:  Pharm Res       Date:  2018-12-03       Impact factor: 4.200

2.  Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery.

Authors:  Mark P Borgman; Omer Aras; Sandra Geyser-Stoops; Edward A Sausville; Hamidreza Ghandehari
Journal:  Mol Pharm       Date:  2009 Nov-Dec       Impact factor: 4.939

3.  Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy.

Authors:  Khaled Greish; Abhijit Ray; Hillevi Bauer; Nate Larson; Alexander Malugin; Daniel Pike; Mohamed Haider; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2011-01-09       Impact factor: 9.776

4.  In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancer.

Authors:  Nate Larson; Sarah Roberts; Abhijit Ray; Brandon Buckway; Darwin L Cheney; Hamidreza Ghandehari
Journal:  Macromol Biosci       Date:  2014-09-04       Impact factor: 4.979

5.  Cathepsin B-sensitive polymers for compartment-specific degradation and nucleic acid release.

Authors:  David S H Chu; Russell N Johnson; Suzie H Pun
Journal:  J Control Release       Date:  2011-10-20       Impact factor: 9.776

Review 6.  Beyond oncology--application of HPMA copolymers in non-cancerous diseases.

Authors:  Xin-Ming Liu; Scott C Miller; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

7.  Noninvasive optical imaging of nanomedicine biodistribution.

Authors:  Sijumon Kunjachan; Felix Gremse; Benjamin Theek; Patrick Koczera; Robert Pola; Michal Pechar; Tomas Etrych; Karel Ulbrich; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  ACS Nano       Date:  2012-10-24       Impact factor: 15.881

8.  Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacy.

Authors:  Huaizhong Pan; Monika Sima; Jiyuan Yang; Jindřich Kopeček
Journal:  Macromol Biosci       Date:  2013-01-22       Impact factor: 4.979

9.  Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs.

Authors:  J Hongrapipat; P Kopecková; S Prakongpan; J Kopecek
Journal:  Int J Pharm       Date:  2007-09-22       Impact factor: 5.875

10.  Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia.

Authors:  Nate Larson; Adam Gormley; Nick Frazier; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2013-04-17       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.